Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study Team.

Source:http://linkedlifedata.com/resource/pubmed/id/11069253

Download in:

View as

General Info

PMID
11069253